Immunic: Q2 Earnings Snapshot

Immunic, Inc. reported a loss of $34.1 million in its second quarter, reporting 80 cents per share loss. These results surpassed Wall Street expectations. The average estimate from six analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share.